To evaluate the role of the OKT4 epitope in human herpesvirus 7 (HHV-7) infection, we studied the susceptibility to HHV-7 infection of CD4 + T cells isolated from two individuals with OKT4 epitope deficiency. HHV-7-infected OKT4-Leu3a + T cells exhibited the characteristic cytopathic effect, reactivity with HHV-7-seropositive serum by immunofluorescence and down-modulation of surface CD4 in a manner similar to HHV-7-infected OKT4+Leu3a + T cells. A semiquantitative PCR revealed that the amounts of HHV-7 replicated in OKT4+Leu3a + T cells and OKT4-Leu3a + T cells were not significantly different. Although it has been reported that OKT4 monoclonal antibody efficiently inhibits HHV-7 infection, the present study demonstrated that the interaction of HHV-7 with CD4 + T cells does not require participation of the epitope defined by OKT4 monoclonal antibody.
To evaluate the role of the OKT4 epitope in human herpesvirus 7 (HHV-7) infection, we studied the susceptibility to HHV-7 infection of CD4 + T cells isolated from two individuals with OKT4 epitope deficiency. HHV-7-infected OKT4-Leu3a + T cells exhibited the characteristic cytopathic effect, reactivity with HHV-7-seropositive serum by immunofluorescence and down-modulation of surface CD4 in a manner similar to HHV-7-infected OKT4+Leu3a + T cells. A semiquantitative PCR revealed that the amounts of HHV-7 replicated in OKT4+Leu3a + T cells and OKT4-Leu3a + T cells were not significantly different. Although it has been reported that OKT4 monoclonal antibody efficiently inhibits HHV-7 infection, the present study demonstrated that the interaction of HHV-7 with CD4 + T cells does not require participation of the epitope defined by OKT4 monoclonal antibody.
Human herpesvirus 7 (HHV-7) is a newly recognized herpesvirus which was originally isolated from the CD4 + T cells of a healthy individual (Frenkel et al., 1990) . It has recently been proposed that the CD4 molecule is an essential component of the receptor for HHV-7 based on the following evidence. First, HHV-7 infection results in a marked decline of surface CD4 expression (Lusso et al., 1994; Furukawa et al., 1994) . Second, monoclonal antibodies (MAbs) against CD4 and the soluble form of CD4 inhibit HHV-7 infection of CD4 + T cells (Lusso et al., I994) . Third, exposure of CD4 + T cells to HHV-7 interferes with infection by human immunodeficiency virus type 1 (HIV-1), and persistent infection by HIV-1 or treatment with the soluble form of HIV-1 gpI20 renders CD4 + T cells resistant to HHV-7 infection (Lusso et al., 1994) . Fourth, treatment of CD4 + T cells with ganglioside or phorboI ester induces CD4 down-modulation and reduces the susceptibility to HHV-7 infection (Yasukawa et al., 1995) .
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The CD4 molecule consists of a 372 amino acid extracellular segment composed of four tandem immunoglobulin-like domains, V1, V2, V3, V4, a 23 amino acid transmembrane domain, and a 38 amino acid cytoplasmic segment (Maddon et al., 1985) . Infection by both HIV-1 and HHV-7 is inhibited by MAbs against the V1 domain of CD4, such as OKT4A and Leu3a (Dalgleish et al., 1984; Lusso et al., 1994) . However, HHV-7 infection is also efficiently inhibited by MAb OKT4, which binds to the V3 domain of CD4. The possibility that inhibition of HHV-7 infection by OKT4 might be the result of the disappearance of the whole CD4 molecule from the cell surface by internalization of the CD4-OKT4 complex is unlikely, since HIV-1 infection is not inhibited by OKT4. These data suggest that the OKT4-binding epitope is essential for the attachment or entry of HHV-7. An inherited variant of CD4 has been recognized, in which the OKT4 epitope is not expressed, whereas regions detected by other MAbs against CD4 are expressed normally (Bach et al., 1981; Joffe & Rabson, 1984; Sato et al., 1984) . In order to evaluate the role of the OKT4 epitope in HHV-7 infection, we studied the susceptibility to HHV-7 infection of CD4 + T cells from two individuals with OKT4 epitope deficiency. We also looked at whether individuals with OKT4 epitope deficiency were infected with HHV-7 by testing for anti-HHV-7 antibody in their sera.
In order to define the alterations in CD4 molecules with OKT4 epitope deficiency, we examined the DNA sequence encoding OKT4 epitope-deficient CD4. The full-length cDNA for CD4 was amplified with primers 5' AACAAAGTGGTG-CTGGGCAAA 3' and 5' AATGGGGCTACATGTTTTCTG-AAA 3' (Maddon et al., 1985) using RT-PCR on mRNAs extracted from peripheral blood lymphocytes of individuals with OKT4 epitope deficiency and a control individual. The cDNAs for CD4 molecule were sequenced using the dideoxy chain termination technique (Sanger et al., 1977) .
The RK strain of HHV-7, kindly provided by Niza FrenkeI (NIH, Bethesda, Md., USA), was grown in cord blood mononuclear cells, which were stimulated with phytohaemagglutinin (PHA), as described previously (Frenkel et al., 1990) . Peripheral blood mononuclear cells were isolated from two healthy unrelated individuals with OKT4 epitope deft- 
~-(a)
1 ciency and a control individual by Ficoll-Conray gradient centrifugation. CD4 + T cells were enriched by treatment of the peripheral blood mononuclear cells with MAbs against CD8, CD56 and complement, as described previously (Yasukawa et al., 1989) . CD4 + T cells were cultured in RPMt 1640 medium supplemented with 10% fetal calf serum (FCS), PHA and interleukin-2 for 5 days. PHA-stimulated CD4 + T cells were then washed and suspended in RPMI 1640 medium supplemented with 10% FCS, and inoculated with HHV-7 at the approximate m.o.i, of 0-1 TCIDs0. The cells were cultured in a 5% CO 2 incubator at 37 °C until cytopathic effects (CPE) became detectable. The titre of the antibody against HHV-7 was determined by indirect immunofluorescence assay as described previously (Yakushijin et al., 1991) . Briefly, HHV-7-infected cord blood lymphocytes were mounted on glass slides and fixed in cold acetone. Serially diluted serum samples were applied to the slide and incubated for 30 rain at 37 °C. After washing, fluorescein isothiocyanate (FITC)-conjugated goat anti-human IgG (Cappel, West Chester, Pa., USA) was added and incubated for 30 rain at 37 °C. After washing, the slides were examined using a fluorescence microscope. The reciprocal titre of serum dilution was expressed as the antibody titre.
Uninfected cells Leu3a
Replication of HHV-7 in the CD4 + T cells was determined by the detection of typical CPE and by indirect immunofluorescence assays using HHV-7-seropositive human serum, as described above. A semiquantitative PCR for the HHV-7 genome was performed as follows. HHV-7-infected cells (1 x 106/mi) were frozen, thawed and sonicated. Twenty I J1 of 10-fold serially diluted virus sample was added to a pellet of 2 x i05 Jurkat cells (human T cell line). DNA was extracted from each sample and amplified for 30 cycles using Taq DNA polymerase (Promega) and the primers 5' TATCCCAGCTGT-TTTCATATAGTAAC 3' and 5' GCCTTGCGGTAGCAC-TAGATTTTTTG 3' (Berneman et a] ., 1992). The amplified products were electrophoresed on a 2% agarose gel and stained with ethidium bromide. The expected product of HHV-7 DNA obtained using these primers consists of 186 bp.
Expression of surface CD4 on HHV-7-infected and uninfected cells was analysed by direct immunofluorescence using a flow cytometer. Cells were stained with FITC-conjugated MAbs OKT4 (Ortho Diagnostic Systems) or Leu3a (BectonDickinson). Cells to be used as unstained negative controls were incubated with FITC-conjugated mouse monoclonal lgG (Becton-Dickinson).
Sequencing of cDNA encoding OKT4-epitope deficient CD4 revealed a single nucleotide base change (CGG to TGG) resulting in substitution of tryptophan at position 240 for arginine in the V3 domain of CD4 (Fig. 1) . This change results in an alteration of hydrophobicity and may cause a conformational change in the V3 domain of CD4.
It appeared that both OKT4 + and OKT4 CD4 + T cells became larger after inoculation with HHV-7, showing the typical CPE of HHV-7. We and other investigators have were inoculated with HHV-7 and cultured for 6 days. The cells were frozen, thawed and sonicated. Samples were serially diluted IO-fold, and the HHV-7 genome was amplified using appropriate primers from 20 i~I samples, reported previously that HHV-7 infection induces a marked decrease in surface CD4 expression (Lusso et al., 1994; Furukawa et al., 1994) . Therefore, we first examined whether down-regulation of surface CD4 was also induced in OKT4-Leu3a + T cells by HHV-7 infection, as HHV-7-infected OKT4 + Leu3a + T cells. Fig. 2 shows representative data from flow cytometric analysis of surface CD4 on OKT4-and OKT4 + CD4 + T cells 6 days after virus inoculation, when CPE was apparently detected. As reported previously, expression of surface CD4 on the OKT4 + T cells was markedly decreased following infection with HHV-7. Similarly, infection with HHV-7 appeared to induce a dramatic decrease in CD4 expression on OKT4-CD4 + T cells, as determined using a MAb against the V1 domain of CD4, Leu3a, Down-regulation of surface CD4 by HHV-7 infection was also detected in CD4 + T cells of another individual with OKT4 epitope deficiency (data not shown). These data suggest that HHV-7 can infect OKT4-CD4 + T ceils as well as OKT4+CD4 + T cells.
To confirm the productive infection of HHV-7 in OKT4-CD4 + T cells, we next performed indirect immunofluorescence using HHV-7-seropositive serum. A productive infection of OKT4-CD4 + T cells by HHV-7 was documented 6 days after virus inoculation, by detection of bright immunofluorescence (data not shown). Replication of HHV-7 in OKT4-CD4 + T cells was also demonstrated by semiquantitative PCR. Fig. 3 shows that approximately the same amounts of HHV-7 genome were detected in OKT4 + and OKT4-CD4 + T cells 6 days after virus inoculation. These data indicate that infection of CD4 + T cells by HHV-7 does not require expression of the OKT4 epitope.
Finally, we examined whether two individuals with OKT4 epitope deficiency were infected with HHV-7 by testing for anti-HHV-7 antibody in their sera. They were both found to be seropositive for HHV-7. Their serum titres of anti-HHV-7 antibody, determined by indirect immunofluorescence, were 80 in both cases.
It has been shown recently that CD4 is an important component of the receptor for HHV-7. Lusso et al. (1994) have reported that MAb OKT4, which binds the V3 domain of CD4, as well as MAbs against the V1 domain of CD4, inhibit HHV-7 infection. Similar data have also been obtained in a series of experiments performed by our group. The present study was performed to clarify the role of the OKT4 binding epitope on HHV-7 infection using CD4 + T cells with OKT4 epitope deficiency. The results showed that HHV-7 infection of CD4 + T cells does not require participation of the epitope defined by MAb OKT4, as is also the case for HIV-1 infection (Hoxie et al., 1986 ). This conclusion was confirmed by the detection of anti-HHV-7 antibody in the sera of two individuals with OKT4 epitope deficiency.
Recent studies on Japanese families with OKT4 epitope deficiency have demonstrated a single nucleotide substitution (CGG to TGG), resulting in arginine being replaced by tryptophan at position 240 in the V3 domain of CD4 (Takenaka et al., 1993) . DNA sequencing of the present cases revealed the identical nucleotide substitution to that reported previously. This amino acid substitution results in a change in hydrophobicity at positions 239 and 240 from that of the CD4 molecule bearing the OKT4 epitope, giving rise to a conformational change in CD4 which accounts for the lack of reactivity with MAb OKT4.
Although the precise mapping of HHV-7-binding regions on CD4 is unknown, the finding that treatment of CD4 + T cells with MAbs against the V1 domain of CD4 and the soluble form of HIV-1 gp120 renders them resistant to HHV-7 infection strongly suggests that the V1 domain of CD4 is a critical component of the receptor for HHV-7 as well as for HIV-1. On the other hand, an MAb against the V3 domain of CD4 inhibited HHV-7 infection but not HIV-1 infection. The mechanism responsible for the inhibition of HHV-7 infection by MAb OKT4 remains obscure. However, one possibility is that binding of OKT4 with the CD4 molecule may induce conformational change in a region other than the OKT4-binding site, which is essential for HHV-7 attachment and entry. Further experiments used mutated recombinant CD4 molecules may elucidate the precise structure of the HHV-7-binding regions on CD4.
